LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
34 hedge funds and large institutions have $16.4M invested in Landos Biopharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$35.1K | |
| 2 | +$28.2K | |
| 3 | +$17K | |
| 4 |
Goldman Sachs
New York
|
+$16.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16K |
Top Sellers
| 1 | -$418K | |
| 2 | -$234K | |
| 3 | -$168K | |
| 4 |
OMC
OUP Management Company
Bala Cynwyd,
Pennsylvania
|
-$156K |
| 5 |
BlackRock
New York
|
-$150K |